Popular diabetes and weight loss drugs New studies have found that appetite can be suppressed. New studies show that it can help reduce the risk of dementia.
The unexpected effects of the two studies recently published in the Jama Neurology Journal have not been specially designed to see the risk. I saw one 26 different clinical trials Among this drug Others saw a health record Thousands of people in this drug.
“This was not a clinical trial to see dementia, but based on the things we saw in the test, there was a hint that new drugs, such as Ozempic, such as Mounjaro, could reduce the risk of dementia for the drugs of drug medical contributions and the health of the editor’s health.
GOUNDER said it is reasonable to potentially affect these drugs.
“What we are looking at is that there is a basic mechanism of damage to blood vessels, a basic mechanism of inflammation. This leads to many chronic diseases that can lead to heart disease, kidney disease, brain damage, stroke or dementia.”
The study was not the first to show Additional benefits In this medicine. According to a 2024 study published in Scientific Journal Addiction, diabetes and weight loss drugs such as Mounjaro and Ozempic can also help. Patients suffering from addiction.
In this study, researchers found that people with opioids or alcohol disorders were Ozempic or those who take similar drugs, with 40% lower opioid overdose and 50% of alcoholism than those who are not in drugs.
But the approach to this drug moved to the Trump administration. Previously, Biden Administration suggested that Medicare begins to deal with drugs for all who are obese as well as people with diabetes or other medical conditions. last week, The Trump administration decided Do not go to that plan.
“I would have been hoping for many people in Medicare to finally guarantee the drug,” GOUNDER said. “But at the same time, this is a trade -off because the US taxpayer has been expensive to extend this report to all of MEDICARE, and he has been watching $ 35 billion for 10 years.”
